
Sign up to save your podcasts
Or


TAVR, baroreflex activation for heart failure, dapagliflozin for HF, and myocardial viability are the topics discussed by John Mandrola in this week's podcast.
By Medscape4.9
862862 ratings
TAVR, baroreflex activation for heart failure, dapagliflozin for HF, and myocardial viability are the topics discussed by John Mandrola in this week's podcast.

1,874 Listeners

327 Listeners

547 Listeners

702 Listeners

500 Listeners

168 Listeners

15 Listeners

16 Listeners

3,379 Listeners

137 Listeners

1,153 Listeners

61 Listeners

516 Listeners

361 Listeners

61 Listeners

27 Listeners

8 Listeners

265 Listeners

436 Listeners

271 Listeners